2026 SoLA

[OP2-1] Composite indices of social determinants of health and coronary artery calcium in Korean

[OP2-2] Regional variation in 30-day case fatality after myocardial infarction in Korea, 2003–2023

[OP2-3] Lean metabolic dysfunction-associated steatotic liver disease as an independent predictor of subclinical coronary artery calcification

[OP2-4] Soluble LDL receptor dynamics in the cholesterol and pharmacogenetics study: simvastatin effects and links to lipid metabolism

[OP2-5] Smoking cessation or reduction after myocardial infarction and subsequent risk of cardiovascular events

[MOP2-1-1] AMPK activation by pioglitazone attenuates cholesterol-induced VSMC phenotypic modulation and atherosclerosis via inhibition of STAT3-mediated inflammation and senescence

[MOP2-1-2] Preventive mechanism of SGLT-2 inhibitor in each organ for diabetic rabbit model

[MOP2-1-3] Protective effects of lactobacillus delbrueckii on metabolic dysfunction and hepatic steatosis in high-fat diet-fed obese mice

[MOP2-1-4] Liraglutide alters gut microbiota and improves endothelium-dependent relaxation in db/db mice

[MOP2-1-5] Empagliflozin binds JNK3 and suppresses c-Jun/c-Fos signaling to protect against diabetic cardiomyopathy

[MOP2-2-1] Macrophage-specific CAR deletion modifies macrophage polarity and induces atherosclerotic plaque formation

[MOP2-2-2] ANGPTL4 preserves endothelial homeostasis and suppresses EndMT in atherosclerosis: extension to a human iPSC-derived atheroid model

[MOP2-2-3] Smooth muscle cell-specific deletion of TXNIP ameliorates medial vascular calcification

[MOP2-2-4] Identification of circular RNAs in ischemic heart disease

[MOP2-2-5] CircAFF3 modulation of p53–ID2 signaling in the retinal pigment epithelium links inflammation with cell death in dry age-related macular degeneration

[MOP2-2-6] Transcriptome analysis of aortic arch in T2DM diabetes-induced atherosclerotic mice

[MOP2-3-1] Combined effects of lipoprotein(a) and HDL cholesterol on cardiovascular mortality: a longitudinal study

[MOP2-3-2] Discordance between apolipoprotein B and low-density lipoprotein cholesterol refines cardiovascular risk stratification in metabolically healthy obesity

[MOP2-3-3] Long-term trends and widening regional variation in mortality from diabetes in Korea, 1998–2023: potential impact of the COVID-19 pandemic

[MOP2-3-4] Placental response to gestational diabetes mellitus suggests compartment-specific fibrinolytic regulation

[MOP2-3-5] Cumulative blood pressure burden above optimal level and risk of cardiovascular disease in patients with diabetes

[MOP2-3-6] Optimal threshold for lipoprotein(a) for cardiovascular event prevention in Korean patients

[MOP2-4-1] Serum phosphate and the progression of arterial stiffness in CKD: from the KNOW-CKD study

[MOP2-4-2] Long-term temporal patterns and regional persistence of district-level obesity, hypertension, and diabetes in Korea, 2008–2024

[MOP2-4-3] Socioeconomic disparities in stroke incidence and case fatality in Korea, 2010–2023

[MOP2-4-4] Single-pill combination vs separate antihypertensive and statin medications and cardiovascular outcomes in young adults

[MOP2-4-5] Socioeconomic disparities in adherence to 24-hour movement guideline and PREVENT–predicted cardiovascular risk: a national survey analysis

[OP3-1] Adiponectin regulates brain endothelial cell function under hyperammonia condition

[OP3-2] TRPC1-mediated calcium dysregulation in cardiac dysfunction and metabolic impairment

[OP3-3] GLP-1 receptor agonist suppresses PDGF-induced VSMC remodeling

[OP3-4] Loss of thyroid hormone receptor beta in myeloid cells promotes atherosclerosis

[OP3-5] Implication of dapagliflozin on endothelial dysfunction by targeting ERK1/2/p90RSK signaling pathway

[OP3-6] Role of ginsenoside Rg2 on angiotensin II-induced phenotypic conversion of vascular smooth muscle cells